Aug. 21, 2024 — An international team of scientists has uncovered a mechanism by which acute myeloid leukemia (AML) cells sustain their growth. AML cells prevent the synthesis of proteins that ...

The work is published in the journal Biomarker Research. B-cell acute lymphoblastic leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most common ...

WE have recently seen a number of patients with acute leukemia of an atypical variety that has received little attention in the literature. These cases smolder along with low-grade clinical ...

However, it has proven difficult to identify such specific antigens in certain cancer types, including acute myeloid leukemia (AML). AML patients are often treated using allogeneic hematopoietic ...

1Toronto General Hospital Research Institute, University Health Network, Toronto, Canada.

No further details about the death were provided. Squire announced last month that he had acute erythroid leukemia, a rare form of acute myeloid leukemia. He was receiving treatment before he died.

In the phase 3 Precision-T trial (NCT05316701), an investigational allogeneic T-cell immunotherapy called Orca-T showed improved cGVHD-free survival vs allo-HSCT for MDS or acute leukemia ...

The gemtuzumab ozogamicin and historical control groups were similar with respect to demographic characteristics ( Table 1). The average age among the gemtuzumab ozogamicin-treated patients was 57 ...

A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis ...

Recent advancements in multi-omics technology have generated significant interest in exploring the role of gut microbiota in the treatment and prognosis of acute myeloid leukemia (AML). Research ...